文献速递细菌感染、耐药与抗菌药物医院感染防控

人工智能分析儿科医院抗生素使用:意大利三级儿科医院探索性研究

Artificial intelligence for analysing antibiotic use: an exploratory study in a tertiary care paediatric hospital in Italy.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

该研究在意大利热那亚一家三级儿科医院回顾性分析2020-2024年数据,探索人工智能在评估抗生素消耗和耐药性中的作用。结果显示Access类抗生素使用增至2024年超过60%,Watch类降至约30%,Reserve类总体上升;金黄色葡萄球菌血流感染MRSA率和耐药指数下降,肠杆菌目耐药趋势混合,多数相关性无统计学显著性。

要点

  • AI辅助分析可识别抗生素管理相关趋势,但专家监督仍必不可少。
  • 2024年Access类抗生素处方超过60%,Watch类降至约30%。
  • 尽管医院活动增加,标准化抗生素消耗保持稳定或下降。

核心结论

  • AI辅助分析识别出与抗菌药物管理相关的趋势,但专家监督仍然至关重要。
  • 需要更广泛的多中心儿科研究纳入患者层面结局以确认AI辅助抗菌药物监测的可行性和有效性。

研究设计与样本

  • 回顾性分析,2020-2024年在意大利热那亚IRCCS Istituto Giannina Gaslini进行。
  • 数据包括金黄色葡萄球菌和肠杆菌目引起的血流感染、静脉用抗生素配药(以DDD表示并按WHO AWaRe分类分层)以及静态和自适应耐药指数。
  • 使用Spearman相关性评估关联,AI(Google Gemini v2.5 Flash)用于数据组织和初步分析,所有输出由作者验证。

主要发现

  • Access类抗生素使用逐步增加,2024年处方超过60%,Watch类使用降至约30%。
  • Reserve类抗生素使用波动但总体呈上升趋势。
  • 尽管医院活动增加,标准化抗生素消耗(DDD/1000出院或患者日)保持稳定或下降。
  • 金黄色葡萄球菌血流感染中,MRSA率和耐药指数均下降。
  • 肠杆菌目显示混合趋势,部分耐药指标上升但总体耐药下降;大多数相关性无统计学显著性。

临床怎么用

  • AI可作为抗菌药物管理监测的辅助工具,用于整理数据和初步分析趋势。
  • AI输出必须经专家审核验证,不能替代临床判断。

局限性

  • 探索性单中心回顾性研究,结果需多中心儿科研究验证。
  • 未纳入患者层面结局,多数相关性无统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Monitoring antibiotic consumption and resistance is central to antimicrobial stewardship (AMS). However, this is particularly challenging in paediatrics due to weight-based dosing and heterogeneous patient populations. OBJECTIVES: To explore the potential role of artificial intelligence (AI) in supporting the evaluation of antibiotic consumption and antimicrobial resistance within a paediatric tertiary-care paediatric hospital in Italy. METHODS: A retrospective analysis (2020-2024) was conducted at the IRCCS Istituto Giannina Gaslini, Genoa. Data included bloodstream infections (BSIs) caused by Staphylococcus aureus and Enterobacterales, intravenous formulations of antibiotic dispensing (expressed as defined daily doses [DDD], stratified according to the World Health Organization AWaRe classification), and both static and adaptive drug resistance indices (DRIs). Spearman's correlation was applied to assess associations. AI (Google Gemini v2.5 Flash) was used for data organization and preliminary analyses; and all outputs were verified by the authors. RESULTS: Use of Access antibiotics increased progressively, exceeding 60% of prescriptions in 2024, whereas Watch antibiotic use decreased to approximately 30%. Reserve antibiotic use fluctuated but showed an overall upward trend. Despite increasing hospital activity, normalized antibiotic consumption (DDD/1000 discharges or patient-days) remained stable or declined. For S. aureus BSIs, methicillin-resistant S.aureus (MRSA) rates and DRIs both declined. Enterobacterales displayed mixed trends, with some resistance indicators increasing, although overall resistance decreased. Most correlations were not statistically significant. CONCLUSIONS: AI-assisted analyses identified stewardship-relevant trends, but expert oversight remained essential. Broader multicentre paediatric studies incorporating patient-level outcomes are warranted to confirm the feasibility and validity of AI-assisted antimicrobial surveillance.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Castagnola E, Mariani M, Saffioti C, et al. Artificial intelligence for analysing antibiotic use: an exploratory study in a tertiary care paediatric hospital in Italy. J Antimicrob Chemother. 2026. PMID: 42090283. doi:10.1093/jac/dkag162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。